Judge approves Pfizer’s $345m EpiPen settlement

18-11-2021

Alex Baldwin

Judge approves Pfizer’s $345m EpiPen settlement

Amy Kerkemeyer / Shutterstock.com

EpiPen buyers have secured final approval of a $345 million settlement with Pfizer in a consumer antitrust suit.


Antitrust, Pfizer, US District Court for the District of Kansas, Daniel Crabtree, EpiPen, Class-action, big pharma

LSIPR